
Quarterly report 2024-Q1
added 05-06-2024
ShockWave Medical Market Cap 2011-2026 | SWAV
As of April 06, 2026 ShockWave Medical has a market cap of $ 12.3 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap ShockWave Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.61 B | 6.82 B | 6.22 B | 3.86 B | 1.07 B | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.61 B | 1.07 B | 5.52 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abbott Laboratories
ABT
|
196 B | $ 102.87 | 0.48 % | $ 179 B | ||
|
Align Technology
ALGN
|
13.9 B | $ 170.6 | -1.23 % | $ 12.8 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
Alphatec Holdings
ATEC
|
2.07 B | $ 10.83 | -3.82 % | $ 1.63 B | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
1.5 B | $ 34.44 | 2.56 % | $ 1.59 B | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
ClearPoint Neuro
CLPT
|
316 M | $ 9.37 | 2.52 % | $ 265 M | ||
|
Accuray Incorporated
ARAY
|
160 M | $ 0.42 | 6.82 % | $ 43.2 M | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.58 | 6.52 % | $ 36.1 M | ||
|
Delcath Systems
DCTH
|
326 M | $ 9.63 | 0.94 % | $ 345 M | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
Electromed
ELMD
|
175 M | $ 23.29 | -1.52 % | $ 197 M | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 36.76 | 1.88 % | $ 5.48 K | ||
|
Boston Scientific Corporation
BSX
|
113 B | $ 62.82 | 1.32 % | $ 93 B | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 81.05 | -0.26 % | $ 47.4 B | ||
|
CONMED Corporation
CNMD
|
1.32 B | $ 34.79 | -2.08 % | $ 1.08 B | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
Aethlon Medical
AEMD
|
3.03 M | $ 2.12 | -1.4 % | $ 3.31 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.03 | 1.43 % | $ 1.63 B | ||
|
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.86 | 9.41 % | $ 1.13 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.53 | -0.42 % | $ 734 M | ||
|
Inogen
INGN
|
160 M | $ 6.21 | -0.96 % | $ 165 M | ||
|
Inspire Medical Systems
INSP
|
1.76 B | $ 54.99 | 2.52 % | $ 1.61 B | ||
|
OrthoPediatrics Corp.
KIDS
|
437 M | $ 16.06 | -1.41 % | $ 377 M | ||
|
IRIDEX Corporation
IRIX
|
16.6 M | $ 0.98 | 3.17 % | $ 16.6 M | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
Integer Holdings Corporation
ITGR
|
2.98 B | $ 86.85 | 0.47 % | $ 3.02 B | ||
|
LivaNova PLC
LIVN
|
3.81 B | $ 63.79 | -1.3 % | $ 3.48 B | ||
|
LENSAR
LNSR
|
71.3 M | $ 6.06 | 1.51 % | $ 72.5 M |